BioCardia

(NASDAQ) BCDA

Current Price$1.01

Market Cap$14.39M

Since IPO (2016)-100%

5 Year-99%

1 Year-54%

1 Month+1%

BioCardia Financials at a Glance

Market Cap

$14.39M

Revenue (TTM)

$0.00

Net Income (TTM)

-$7.78M

EPS (TTM)

-$1.03

P/E Ratio

-0.93

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Price

$1.01

Volume

475,619.907

Open

$0.95

Price

$1.01

Volume

475,619.907

Open

$0.95

Previous Close

$1.00

Daily Range

$0.93 - $1.02

52-Week Range

$0.78 - $2.45

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Price

$1.01

Volume

475,619.907

Open

$0.95

Previous Close

$1.00

Daily Range

$0.93 - $1.02

52-Week Range

$0.78 - $2.45

Estimated Earnings Date

Aug 12, 2026

BCDA News

BioCardia Narrows Loss in Fiscal Q2

Motley Fool Markets TeamAug 11, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioCardia

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Peter Alan Altman, PhD

Website

www.biocardia.com

Headquarters

Sunnyvale, CA 94085, US

BCDA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-5456.14%

Return on Capital

-581.73%

Return on Assets

-454.15%

Earnings Yield

-1.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.39M

Shares Outstanding

14.88M

Volume

475.62K

Avg. Volume

2.79M

Financials (TTM)

Gross Profit

-$1.78M

Operating Income

-$7.82M

EBITDA

-$7.35M

Operating Cash Flow

-$7.48M

Capital Expenditure

-$10.00K

Free Cash Flow

-$7.49M

Cash & ST Invst.

$951.00K

Total Debt

$412.00K

BioCardia Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$124.00K

+91.9%

Gross Margin

0.00%

N/A

Market Cap

$14.39M

N/A

Market Cap/Employee

$846.48K

N/A

Employees

N/A

Net Income

-$2.26M

+16.7%

EBITDA

-$2.14M

+20.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$951.00K

+0.2%

Total Debt

$412.00K

-51.5%

Accounts Receivable

$20.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$412.00K

+3.5%

Return on Assets

-4.54%

N/A

Return on Invested Capital

7.33%

N/A

Free Cash Flow

-$1.66M

-2.7%

Operating Cash Flow

-$1.66M

-2.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INABIN8bio, Inc.

INABIN8bio, Inc.$1.46+0.00%

PHIOPhio Pharmaceuticals Corp.

PHIOPhio Pharmaceuticals Corp.$1.04-0.95%

KPRXKiora Pharmaceuticals, Inc.

KPRXKiora Pharmaceuticals, Inc.$2.60+5.26%

APVOAptevo Therapeutics Inc.

APVOAptevo Therapeutics Inc.$4.63-2.53%

APREAprea Therapeutics, Inc.

APREAprea Therapeutics, Inc.$0.83+4.33%

CELZCreative Medical Technology Holdings, Inc.

CELZCreative Medical Technology Holdings, Inc.$1.97+2.07%

ALZNAlzamend Neuro Inc

ALZNAlzamend Neuro Inc$1.37+12.30%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$17.29+0.01%

PFEPfizer

PFEPfizer$24.72-0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.44-0.10%

TAT&T

TAT&T$22.81+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.56+0.10%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.82-0.12%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.60-0.01%

Questions About BCDA

What is the current price of BioCardia?

BioCardia is trading at $1.00 per share.

What is the 52-week range for BioCardia?

Over the past 52 weeks, BioCardia has traded between $0.78 and $2.45.

How much debt does BioCardia have?

As of the most recent reporting period, BioCardia reported total debt of $412.00K.

How much cash does BioCardia have on hand?

BioCardia reported $951.00K in cash and cash equivalents in its most recent financial results.

What is BioCardia’s dividend yield?

BioCardia does not currently have a dividend yield.

BioCardia

BioCardia Financials at a Glance

BCDA News

BioCardia Narrows Loss in Fiscal Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioCardia

BCDA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioCardia Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BCDA

What is the current price of BioCardia?

What is the 52-week range for BioCardia?

How much debt does BioCardia have?

How much cash does BioCardia have on hand?

What is BioCardia’s dividend yield?

Premium Investing Services